XBI vs XLB

SPDR S&P Biotech ETF vs Materials Select Sector SPDR

Quick take
  • • XLB has the lower expense ratio at 0.08% vs 0.35% for XBI.
  • • XLB pays a higher dividend yield (1.64%).

Side-by-side metrics

MetricXBIXLB
Expense ratio
Annual fee. Lower is better.
0.35%0.08%
Dividend yield
Trailing 12-month yield.
0.35%1.64%
AUM
Assets under management — bigger funds are typically more liquid.
$10.92B$8.45B
YTD return
28.80%18.23%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
1.010.76
P/E ratio
—22.03
Last price
$156.41$52.98
Inception
——
Issuer
State StreetState Street

XBI top holdings

Top holdings · XBI
MRNAModerna Inc2.37%
NTRANatera Inc1.82%
HALOHalozyme Therapeutics Inc1.77%
TWSTTwist Bioscience Corp1.77%
BIIBBiogen Inc1.75%
AMGNAmgen Inc1.73%
EXELExelixis Inc1.73%
UTHRUnited Therapeutics Corp1.72%
ABBVAbbVie Inc1.71%
GILDGilead Sciences Inc1.70%
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%

XLB top holdings

Top holdings · XLB
LINLinde PLC12.84%
NEMNewmont Corp6.09%
VMCVulcan Materials Co5.14%
ECLEcolab Inc5.08%
APDAir Products and Chemicals Inc4.89%
MLMMartin Marietta Materials Inc4.86%
FCXFreeport-McMoRan Inc4.86%
NUENucor Corp4.85%
STLDSteel Dynamics Inc4.75%
SHWSherwin-Williams Co4.73%
Sector breakdown · XLB
Consumer Cyclical17.7%
Basic Materials82.3%

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.

About XLB

XLB (Materials Select Sector SPDR) is S&P 500 materials sector. Managed by State Street, the fund carries $8.4B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.64%. Its largest holding is Linde PLC (LIN), which represents 12.8% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 17.7%.